Are You Using a Drug to Prevent Alzheimer's Disease?

In two thousand 13, we began immunizing people who were cognitively unimpaired against alsheimer's disease with an anti amaloid immunitherapy called crenesmab. We continued the treatment in the study for rough eight years. The top line results were that we didn't achieve our primary objectives of showing delayed worsening of memory and other thinking ability on two key outcomes. But there are some tant lizing clues in favor of drug versus placebo, but these do not reach statistical significance.